Sensory Predominant Chronic Inflammatory Demyelinating Polyneuropathy (SP-CIDP)
Diagnostics of Sensory Ataxia in Patients with Sensory Predominant Chronic Inflammatory Demyelinating Polyneuropathy from Republic of Sakha (Yakutia) and Krasnoyarsk Region
10
Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
9
Isolated unilateral palatal and vocal cord palsy as an initial presentation of chronic inflammatory demyelinating polyradiculoneuropathy
5
Pathway construction of chronic inflammatory demyelinating polyneuropathy (CIPD): a neurodegenerative disease
7
Child Neurology: Chronic inflammatory demyelinating polyradiculoneuropathy in children
6
A study of Peripheral Neuropathy in HIV infected patients.
110
Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy
9
Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
5
A REVIEW ON PATHOGENESIS AND TREATMENT OF DIABETIC NEUROPATHY
13
Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies
10
Autonomic dysfunction in chronic inflammatory demyelinating polyneuropathy.
92
A Case of Acquired Chronic Inflammatory Demyelinating Polyneuropathy
8
Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children
5
Novel pathomechanisms in inflammatory neuropathies
17
Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy
9
Neutrophil–lymphocyte ratio and response to plasmapheresis in Guillain–Barré syndrome: a prospective observational study
6
Clinical and electrophysiological features of post-traumatic Guillain-Barré syndrome
7
Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans
20
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
39
Autonomic Dysfunction in Iraqi Patients with Chronic Inflammatory Demyelinating Polyneuropathy
9